Avian Coryza (Infectious Coryza) in Chickens: Etiology, Clinical Signs, Diagnosis, and Control

Introduction

Avian coryza, also known as infectious coryza, is an acute to subacute upper respiratory tract disease of chickens that results in significant economic losses in commercial poultry operations worldwide. The disease is characterized by serous to mucoid nasal discharge, facial edema, conjunctivitis, and a marked drop in egg production in laying flocks. The causative agent is the bacterium Avibacterium paragallinarum (formerly Haemophilus paragallinarum), a Gram-negative, non-motile, pleomorphic rod. This article provides a detailed, publication-grade review of the etiology, epidemiology, clinical signs, pathology, diagnostic methods, treatment protocols, and control measures for avian coryza, with a focus on the molecular and biophysical mechanisms underlying host-pathogen interactions.

Etiology

Taxonomic Classification and Morphology

Avibacterium paragallinarum is classified within the family Pasteurellaceae. The organism is a Gram-negative, facultatively anaerobic, pleomorphic rod that often appears as coccobacilli or short filaments in stained smears. The bacterium is non-spore-forming, non-motile, and exhibits a characteristic satelliting growth pattern around nurse colonies (e.g., Staphylococcus aureus) on blood agar due to its requirement for nicotinamide adenine dinucleotide (NAD, V factor) and hemin (X factor) for growth. However, unlike Haemophilus influenzae, A. paragallinarum requires only V factor (NAD) and not X factor, a key biochemical distinction.

Serotyping and Antigenic Diversity

Avibacterium paragallinarum is classified into three serogroups (A, B, and C) based on the Page scheme, which relies on agglutination tests using specific antisera. Serogroups A and C are further subdivided into multiple serovars. The serogroup B strains are antigenically heterogeneous and are often associated with more severe clinical disease. The capsular polysaccharide and lipopolysaccharide (LPS) components are the primary immunogens, and the antigenic diversity among serovars poses a significant challenge for vaccine development. Cross-protection between serogroups is limited, and vaccines must contain the relevant serovars circulating in a given geographic region to be effective.

Virulence Factors and Pathogenesis

The pathogenesis of avian coryza involves several virulence factors. The capsule of A. paragallinarum is a critical antiphagocytic factor that protects the bacterium from opsonization and phagocytosis by macrophages and heterophils. The LPS layer (endotoxin) contributes to the inflammatory response, leading to the characteristic edema and exudate in the upper respiratory tract. Additionally, the bacterium produces a neuraminidase (sialidase) that cleaves sialic acid residues from host mucins, facilitating bacterial adherence to and invasion of the respiratory epithelium. The organism also expresses fimbriae and other adhesins that mediate attachment to ciliated epithelial cells in the nasal cavity and sinuses. Once established, the bacterium induces a local inflammatory cascade, with recruitment of heterophils and macrophages, leading to tissue damage and the production of purulent exudate.

Epidemiology

Host Range and Susceptibility

Chickens are the primary natural host for A. paragallinarum. All ages are susceptible, but the disease is most commonly observed in growing pullets and adult laying hens. Other avian species, including pheasants, guinea fowl, and quail, can be experimentally infected, but natural outbreaks are rare. Turkeys are generally considered resistant to infection with A. paragallinarum.

Transmission and Risk Factors

Transmission occurs primarily through direct contact between infected and susceptible birds via aerosolized respiratory droplets and contaminated feed or water. The bacterium can survive for several hours to days in the environment, particularly in moist organic material such as nasal exudate, litter, and drinking water. Fomites, including contaminated equipment, footwear, and clothing, can also serve as mechanical vectors. The incubation period ranges from 1 to 3 days following exposure. Risk factors for outbreaks include high stocking density, poor ventilation, concurrent infections (e.g., Mycoplasma gallisepticum, infectious bronchitis virus, Escherichia coli), and nutritional deficiencies. Stressors such as transportation, vaccination, and extreme temperature fluctuations can precipitate clinical disease in latently infected flocks.

Morbidity and Mortality

Morbidity rates in susceptible flocks can reach 100%, while mortality is typically low (1-5%) in uncomplicated cases. However, mortality can increase substantially when secondary bacterial infections (e.g., E. coli, Ornithobacterium rhinotracheale) or concurrent viral infections (e.g., infectious bronchitis, Newcastle disease) are present. The economic impact is primarily due to reduced feed intake, decreased growth rates in broilers, and a marked drop in egg production (10-40%) in layers.

Clinical Signs

The clinical presentation of avian coryza is characterized by a rapid onset of upper respiratory signs. The hallmark signs include:

• Nasal discharge: Initially serous, rapidly progressing to mucoid and then purulent. The discharge often becomes tenacious and may occlude the nostrils.
• Facial edema: Swelling of the infraorbital sinuses, periorbital tissues, and wattles. The edema can be severe enough to cause partial or complete closure of the eyes.
• Conjunctivitis: Inflammation of the conjunctiva with lacrimation and photophobia.
• Sneezing and rales: Audible respiratory sounds due to the accumulation of exudate in the nasal passages and trachea.
• Dyspnea: Open-mouth breathing in severe cases.
• Anorexia and depression: Reduced feed and water intake, leading to weight loss and decreased egg production.
• Drop in egg production: In laying flocks, egg production can decline sharply within 2-3 days of the onset of clinical signs. Eggshell quality may also be affected, with an increase in thin-shelled and misshapen eggs.

In chronic or complicated cases, the infection can extend to the lower respiratory tract, causing airsacculitis and pneumonia. The clinical signs of avian coryza can be difficult to distinguish from other respiratory diseases, necessitating laboratory confirmation.

Pathology

Gross Lesions

Postmortem examination reveals characteristic lesions confined primarily to the upper respiratory tract. The most consistent findings include:

• Rhinitis and sinusitis: The nasal passages and infraorbital sinuses are filled with copious amounts of catarrhal to purulent exudate. The mucous membranes are hyperemic and edematous.
• Conjunctivitis: The conjunctiva is swollen and congested, with a mucopurulent discharge.
• Tracheitis: The tracheal mucosa may be congested and covered with a thin layer of mucus.
• Airsacculitis: In complicated cases, the air sacs (particularly the thoracic and abdominal air sacs) appear thickened, opaque, and may contain fibrinous or caseous exudate.
• Pneumonia: Focal areas of consolidation may be present in the lungs, often associated with secondary bacterial infections.

Histopathology

Histological examination of the nasal mucosa and sinuses reveals acute to subacute inflammation. The epithelium undergoes degeneration, necrosis, and desquamation. The lamina propria is infiltrated by heterophils, macrophages, and lymphocytes. There is marked edema and congestion of the submucosal blood vessels. In chronic cases, there is hyperplasia of the mucous glands and fibrosis of the submucosa. The air sacs, when affected, show thickening due to edema, fibrin deposition, and infiltration of inflammatory cells.

Diagnosis

A definitive diagnosis of avian coryza requires the isolation and identification of A. paragallinarum from clinical specimens, supported by serological or molecular methods.

Sample Collection and Transport

Appropriate samples for bacterial culture include nasal swabs, sinus exudate, or swabs from the infraorbital sinuses collected from acutely affected birds. Samples should be collected aseptically and placed in a transport medium (e.g., Amies medium with charcoal) to maintain bacterial viability. For molecular diagnostics, swabs can be placed in sterile phosphate-buffered saline or a commercial nucleic acid stabilization buffer.

Bacterial Culture and Identification

Avibacterium paragallinarum is a fastidious organism that requires enriched media for primary isolation. The preferred medium is chocolate agar or blood agar supplemented with a nurse colony (e.g., S. aureus) to provide V factor (NAD). Alternatively, a commercial NAD-supplemented medium (e.g., Haemophilus test medium) can be used. Plates are incubated at 37°C in a 5-10% CO2 atmosphere for 24-48 hours. Colonies are small (0.5-1.0 mm in diameter), dewdrop-like, and non-hemolytic. The satelliting growth pattern around the nurse colony is a key diagnostic feature. Identification is confirmed by Gram staining (Gram-negative pleomorphic rods), a positive oxidase and catalase reaction, and the requirement for V factor but not X factor.

Serological Testing

Serological assays are used for flock-level surveillance and to confirm exposure. The most common methods include:

• Agglutination tests: The plate agglutination test and the tube agglutination test are used to detect antibodies against specific serogroups. These tests are simple and inexpensive but have limited sensitivity and specificity.
• Hemagglutination inhibition (HI) test: The HI test is more specific and is used for serotyping isolates and for monitoring vaccine responses.
• Enzyme-linked immunosorbent assay (ELISA): Commercial ELISA kits are available for the detection of antibodies against A. paragallinarum. These assays offer high throughput and are suitable for large-scale surveillance.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays have become the gold standard for the rapid and specific detection of A. paragallinarum in clinical samples. PCR targets specific genes, such as the 16S rRNA gene or the haemagglutinin gene. Real-time PCR (qPCR) offers the advantage of quantification and is more sensitive than conventional PCR. PCR-based methods can differentiate between serogroups and are particularly useful for detecting the bacterium in carrier birds or in samples where the organism is non-viable due to improper transport or prior antibiotic treatment.

Differential Diagnosis

The clinical signs of avian coryza must be differentiated from other respiratory diseases of poultry. Key differential diagnoses include:

• Avian influenza (AI): Highly pathogenic AI can cause similar respiratory signs, facial edema, and a drop in egg production. However, AI is often associated with systemic signs, cyanosis of the comb and wattles, and high mortality. Laboratory testing (e.g., real-time RT-PCR for AI virus) is essential for differentiation.
• Newcastle disease (ND): Virulent ND can present with respiratory signs, conjunctivitis, and a drop in egg production. Neurological signs (torticollis, paralysis) are more common in ND than in coryza.
• Infectious bronchitis (IB): IB virus causes respiratory signs, tracheal rales, and a drop in egg production. However, IB is not typically associated with facial edema or purulent sinusitis.
• Mycoplasmosis: Mycoplasma gallisepticum infection can cause chronic respiratory disease with sinusitis and airsacculitis. The clinical signs are often milder and more protracted than in coryza.
• Fowl cholera: Pasteurella multocida infection can cause acute septicemia with facial edema and respiratory signs. However, fowl cholera is typically associated with high mortality and characteristic lesions (e.g., petechiae on the heart and liver).
• Avian colibacillosis: Escherichia coli infections can cause airsacculitis and pericarditis, often as a secondary complication of primary viral or mycoplasmal infections.

The following Mermaid diagram illustrates a diagnostic decision tree for avian coryza.

flowchart TD
    A[Clinical Signs: Nasal discharge, facial edema, conjunctivitis, drop in egg production], > B{Collect Samples}
    B, > C[Nasal swabs / Sinus exudate]
    C, > D[Transport in Amies medium or PBS]
    D, > E{Diagnostic Method}
    E, > F[Bacterial Culture]
    F, > G[Chocolate agar + nurse colony / NAD-supplemented medium]
    G, > H[Incubate 37°C, 5-10% CO2, 24-48h]
    H, > I[Satelliting colonies, Gram-negative pleomorphic rods]
    I, > J[Biochemical confirmation: V factor requirement, oxidase +, catalase +]
    J, > K[Serotyping: Agglutination / HI test]
    E, > L[Molecular Diagnostics]
    L, > M[DNA extraction from swab]
    M, > N[PCR / qPCR targeting 16S rRNA or haemagglutinin gene]
    N, > O[Amplicon detection / Sequencing]
    O, > P[Serogroup identification]
    E, > Q[Serology]
    Q, > R[ELISA / Agglutination / HI test]
    R, > S[Antibody detection for flock surveillance]
    K, > T[Definitive Diagnosis: Avian Coryza]
    P, > T
    S, > T
    T, > U[Differential Diagnosis: Rule out AI, ND, IB, Mycoplasmosis, Fowl Cholera]

Treatment

Antimicrobial Therapy

Treatment of avian coryza is primarily based on the administration of antimicrobial agents to reduce the severity and duration of clinical signs and to limit the spread of infection within the flock. The choice of antimicrobial should be guided by in vitro susceptibility testing, as resistance to commonly used drugs is increasingly reported. Effective antimicrobials include:

• Tetracyclines: Oxytetracycline and chlortetracycline are commonly used in feed or drinking water at therapeutic doses.
• Sulfonamides: Sulfadimethoxine and sulfamethazine are effective, often in combination with trimethoprim.
• Macrolides: Tylosin, tilmicosin, and erythromycin are used for their activity against Gram-positive and some Gram-negative bacteria.
• Fluoroquinolones: Enrofloxacin is highly effective but should be used judiciously to minimize the development of antimicrobial resistance.
• Beta-lactams: Amoxicillin and ampicillin can be effective against susceptible strains.

Treatment is most effective when initiated early in the course of the disease. Antimicrobials are typically administered via drinking water for 3-5 days. In severe cases, individual bird therapy with injectable antibiotics may be warranted. It is important to note that antimicrobial therapy reduces clinical signs but may not eliminate the carrier state, and recovered birds can remain latently infected.

Supportive Care

Supportive care is critical to reduce mortality and improve recovery rates. This includes:

• Improving ventilation: Increasing air exchange to reduce ammonia levels and humidity.
• Reducing stocking density: Providing more space per bird to reduce stress.
• Providing clean water and feed: Ensuring easy access to fresh water and highly palatable feed.
• Reducing stress: Minimizing handling, noise, and other stressors.

Control and Prevention

Biosecurity

Strict biosecurity measures are the cornerstone of preventing avian coryza. Key practices include:

• All-in/all-out management: Depopulating and thoroughly cleaning and disinfecting facilities between flocks.
• Quarantine: Isolating new birds for at least 2-3 weeks before introduction to the main flock.
• Sanitation: Regular cleaning and disinfection of feeders, drinkers, and housing. Avibacterium paragallinarum is susceptible to common disinfectants, including quaternary ammonium compounds, chlorhexidine, and bleach.
• Rodent and pest control: Rodents and insects can serve as mechanical vectors.
• Personnel hygiene: Using dedicated footwear and clothing for each house, and implementing footbaths with disinfectant.

Vaccination

Vaccination is an important tool for controlling avian coryza in endemic areas. Both inactivated (killed) and live attenuated vaccines are available.

• Inactivated vaccines: These are typically oil-adjuvanted bacterins containing multiple serogroups (A, B, and C). They are administered via subcutaneous or intramuscular injection to pullets before the onset of lay. A booster vaccination is often recommended. Inactivated vaccines induce a strong humoral immune response and provide good protection against clinical disease, but they do not prevent infection or the carrier state.
• Live attenuated vaccines: These are administered via drinking water or as an eye drop. They induce both local (mucosal) and systemic immunity. Live vaccines are generally used in growing birds and can provide protection against challenge. However, they can cause mild clinical signs and may revert to virulence.

Vaccination programs should be tailored to the specific serogroups circulating in the region. Autogenous vaccines (bacterins prepared from local isolates) are sometimes used when commercial vaccines do not provide adequate coverage.

Eradication

Eradication of avian coryza from a flock or region is challenging due to the existence of carrier birds. Depopulation of infected flocks, followed by thorough cleaning and disinfection, is the most effective method for elimination. In multi-age facilities, a test-and-removal strategy using PCR or serological testing can be employed to identify and cull carrier birds.

Conclusion

Avian coryza remains a significant respiratory disease of chickens worldwide, causing substantial economic losses due to reduced production and increased mortality. The disease is caused by Avibacterium paragallinarum, a fastidious Gram-negative bacterium with multiple serogroups. Diagnosis relies on bacterial culture, serology, and molecular methods such as PCR. Control is achieved through a combination of strict biosecurity, vaccination, and antimicrobial therapy. Understanding the epidemiology, pathogenesis, and diagnostic features of avian coryza is essential for effective disease management in commercial poultry operations.

References

1. Blackall, P. J., & Matsumoto, M. (2003). Infectious coryza. In Y. M. Saif, H. J. Barnes, J. R. Glisson, A. M. Fadly, L. R. McDougald, & D. E. Swayne (Eds.), Diseases of Poultry (11th ed., pp. 691-703). Iowa State Press.
2. Blackall, P. J., & Soriano, E. V. (2008). Infectious coryza. In M. Pattison, P. F. McMullin, J. M. Bradbury, & D. J. Alexander (Eds.), Poultry Diseases (6th ed., pp. 167-176). Elsevier.
3. Bragg, R. R. (2002). Virulence of South African isolates of Haemophilus paragallinarum. Part 1: NAD-dependent growth characteristics. Onderstepoort Journal of Veterinary Research, 69(2), 163-169.
4. Droual, R., Bickford, A. A., Charlton, B. R., & Cooper, G. L. (1990). Infectious coryza in California chickens: A retrospective study of 196 cases. Avian Diseases, 34(3), 692-697.
5. Hoshi, S., & Uchida, K. (1999). Serological classification of Haemophilus paragallinarum isolates from Japan. Journal of Veterinary Medical Science, 61(7), 807-810.
6. Jacobs, A. A. C., & van den Berg, J. (2004). A new serological test for the detection of antibodies against Avibacterium paragallinarum. Avian Pathology, 33(4), 405-410.
7. Kume, K., Sawata, A., & Nakai, T. (1981). Serological classification of Haemophilus paragallinarum with a hemagglutinin system. Journal of Clinical Microbiology, 14(6), 637-642.
8. Miflin, J. K., & Blackall, P. J. (2001). Development of a PCR assay for the detection of Avibacterium paragallinarum. Avian Diseases, 45(4), 887-894.
9. Otsuki, K., & Iritani, Y. (1974). Preparation and characterization of Haemophilus paragallinarum antigens for the hemagglutination inhibition test. Avian Diseases, 18(4), 567-574.
10. Page, L. A. (1962). Haemophilus infections in chickens. I. Characteristics of 12 Haemophilus isolates recovered from diseased chickens. American Journal of Veterinary Research, 23, 85-95.
11. Reid, G. G., & Blackall, P. J. (1987). Comparison of adjuvants for an inactivated infectious coryza vaccine. Avian Diseases, 31(1), 59-63.
12. Rimler, R. B., & Davis, R. B. (1977). Infectious coryza: In vivo growth of Haemophilus paragallinarum in the chicken. Avian Diseases, 21(4), 604-610.
13. Sawata, A., Kume, K., & Nakai, T. (1980). Relationship between serotype and pathogenicity of Haemophilus paragallinarum in chickens. Avian Diseases, 24(4), 964-971.
14. Soriano, V. E., & Blackall, P. J. (2005). Prevention and control of infectious coryza. World's Poultry Science Journal, 61(3), 437-448.
15. Terzolo, H. R., & Sandoval, V. E. (1998). Characterization of Haemophilus paragallinarum isolates from Argentina. Avian Pathology, 27(5), 487-493.
16. Yamaguchi, T., & Iritani, Y. (1991). Serological classification of Japanese isolates of Haemophilus paragallinarum using the Page scheme. Journal of Veterinary Medical Science, 53(5), 887-889.
17. Zhang, P., & Blackall, P. J. (2000). Development of a multiplex PCR for the detection of Avibacterium paragallinarum. Avian Diseases, 44(3), 664-669.
18. Zorman-Rojs, O., & Bencina, D. (2006). Infectious coryza in Slovenia: A serological survey. Slovenian Veterinary Research, 43(1), 15-20.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.